USTEKINUMAB-TTWE
NDC 82009-161 · Quallent Pharmaceuticals Health LLC
Generic nameustekinumab-ttwe
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)USTEKINUMAB
Strength45 mg/.5mL
Pharmacologic classInterleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
Marketing categoryBLA
Packages
82009-161-94 — .5 mL in 1 VIAL (82009-161-94)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
65219-824 — ustekinumab-aauz, 65219-826 — ustekinumab-aauz, 65219-828 — ustekinumab-aauz, 65219-862 — ustekinumab-aauz, 65219-866 — ustekinumab-aauz, 72606-027 — ustekinumab-stba, 72606-028 — ustekinumab-stba, 72606-029 — ustekinumab-stba, 72606-060 — ustekinumab-stba, 82009-160 — ustekinumab-ttwe, 82009-162 — ustekinumab-ttwe, 82009-163 — ustekinumab-ttwe, 83257-023 — ustekinumab, 83257-024 — ustekinumab, 83257-025 — ustekinumab, 83257-026 — ustekinumab, 83457-651 — ustekinumab-ttwe, 83457-652 — ustekinumab-ttwe, 84612-055 — ustekinumab-auub, 84612-066 — ustekinumab-auub, +20 more